Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$35.68 - $44.71 $995,472 - $1.25 Million
-27,900 Reduced 16.67%
139,466 $5.75 Million
Q3 2022

Nov 14, 2022

BUY
$42.51 - $54.02 $7.11 Million - $9.04 Million
167,366 New
167,366 $7.33 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $308,850 - $368,004
-5,427 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $347,436 - $389,224
5,427 New
5,427 $368,000
Q1 2021

May 17, 2021

SELL
$53.26 - $68.08 $375,269 - $479,691
-7,046 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $305,866 - $398,169
7,046 New
7,046 $397,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.